Zentalis Pharmaceuticals (ZNTL) Minority Interest (2019 - 2023)

Zentalis Pharmaceuticals has reported Minority Interest for 5 years, with the latest figure at $107000.0 in Q4 2023.

• For the quarter ending Q4 2023, Minority Interest fell 51.58% year-over-year to $107000.0; the trailing twelve-month figure through Dec 2023 stood at $107000.0 (down 51.58% YoY), and the FY2023 full-year result was $107000.0, down 51.58% from the prior year.
• Minority Interest for Q4 2023 stood at $107000.0, down from $129000.0 in the prior quarter.
• The five-year high for Minority Interest was $24.8 million in Q4 2020, with the low at $107000.0 in Q4 2023.
• Average Minority Interest over 5 years is $8.2 million, with a median of $528000.0 recorded in 2021.
• Year-over-year, Minority Interest surged 263.51% in 2020 and sank 98.6% in 2022.
• Tracing ZNTL's Minority Interest over 5 years: stood at $6.8 million in 2019, then surged by 263.51% to $24.8 million in 2020, then tumbled by 97.87% to $528000.0 in 2021, then sank by 58.14% to $221000.0 in 2022, then tumbled by 51.58% to $107000.0 in 2023.
• The last three Minority Interest figures came in at $107000.0 (Q4 2023), $129000.0 (Q3 2023), and $141000.0 (Q2 2023), per Business Quant data.

Peer Comparison